America’s Health Insurance Plans Issues Statement on Lower Medicare Premiums
"When it comes to prescription drugs, the problem is the price. And prices for branded drugs are out of control and out of reach for many Americans who need them.
"However, when
"This afternoon CMS announced that 2019 Part D premiums are declining, reaffirming that the Part D coverage gap or 'donut hole' drug discounts save money for patients. The changes made in the BBA lower premiums for Medicare beneficiaries, increase manufacturer discounts for brand name drugs in the donut hole, and extend discounts to "biosimilar" versions of high priced biotech drugs.
"Despite aggressive efforts by the pharmaceutical industry to reverse these changes, we urge
By
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News